This Study in Healthy Men Tests How Itraconazole Influences the Amount of BI 1015550 in the Blood
Status:
Completed
Trial end date:
2018-07-20
Target enrollment:
Participant gender:
Summary
The primary objective of this trial is to investigate whether and to what extent
co-administration of multiple doses of itraconazole affect single dose pharmacokinetics of
BI1015550, i.e. to compare the relative bioavailability of 6 mg BI 1015550 when given alone
(reference, treatment R) to the relative bioavailability of 6 mg of BI 1015550 given on the
4th day of a 12-day-treatment with itraconazole (test, treatment T) following oral
administration in healthy male subjects.